Table 1 |
||||
|
Breast cancer data sets used |
||||
| Study |
Cohort name |
Platform |
ER+ samples |
Events (RIP/DM) |
|
|
||||
| van de Vijver [18] |
NKI2 |
oligos Agilent |
226 |
45 |
| Wang [11] |
EMC |
oligos Affymetrix |
208 |
80 |
| Naderi [12] |
NCH |
oligos Agilent |
93 |
21 |
| Sotiriou [25] |
JRH-1 |
spotted cDNA |
65 |
20 |
| Miller [26] |
UPP |
oligos Affymetrix |
213 |
49 |
| Sotiriou [4] |
JRH-2 |
oligos Affymetrix |
72 |
17 |
|
|
||||
|
Study, cohort name, microarray platform, number of ER+ patients and death (or surrogate distant metastasis) events among ER+ cases. The cohorts are described in [4,11,12,18,25,26]. |
||||
|
Teschendorff et al. Genome Biology 2006 7:R101 doi:10.1186/gb-2006-7-10-r101 |
||||
